Transcribed
Transcribed
Podcast Description
Transcribed is your front-row seat to the fascinating world of biotech. Hosted by two curious minds bridging science and business, this podcast brings you insightful conversations with leading voices in biotechnology. Whether you're a student navigating STEM or business, or simply a curious listener, Transcribed delivers practical tools, career advice, and behind-the-scenes stories that make the complex world of biotech accessible and inspiring.
Podcast Insights
Content Themes
The podcast explores a variety of themes centered around biotechnology, including innovation in life sciences, career advice for STEM students, and behind-the-scenes stories from the biotech industry. For example, episodes might delve into entrepreneurship challenges, the importance of mentorship in biotech, or the dynamics of scaling biotech startups.
Transcribed is your front-row seat to the fascinating world of biotech. Hosted by two curious minds bridging science and business, this podcast brings you insightful conversations with leading voices in biotechnology. Whether you’re a student navigating STEM or business, or simply a curious listener, Transcribed delivers practical tools, career advice, and behind-the-scenes stories that make the complex world of biotech accessible and inspiring.
In this episode of our biotech podcast, we sit down with Patrick Most – biotech entrepreneur, founder of Aavigen, and professor of cardiology in Heidelberg University, Germany. Together, we explore his journey, insights into gene therapy, and how it will change the therapeutic landscape.Hosted by Meronn and Pierre00:00:00 Intro00:01:40 Why gene therapy?00:03:20 From Academia to Biotech00:12:20 pitching a startup00:13:30 pitfalls when translating academic findings00:17:00 Accessibility of gene therapy00:19:40 Viruses to cure diseases???00:28:00 AI in gene therapy00:30:40 Business model00:34:05 Clearing misconceptions00:36:10 Patience as a biotech founder00:43:10 Day to day as professor and biotech founder00:45:00 Spinning out early or later?00:47:00 The role of a CEO00:51:35 Choosing Co-Founders00:54:10 Corona00:56:00 Biotech winter00:58:30 Networking01:01:00 How to get started as a student01:02:45 Impact of being a CEO on professor and vice versa01:05:00 US vs. Germany01:08:00 Doing something differently?01:10:03 When will Gene therapy cure heart disease?01:13:00 Conclusion#genetherapy #biotechnology #PatrickMost #transcribed #AAV #virus #research #professor #Heidelberg #innovation
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.